Early  	Early  	 JJ	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
multiple  	multiple  	 JJ	O
sclerosis 	sclerosis 	 NN	O
:  	:  	 :	O
a  	a  	 DT	O
Latin  	Latin  	 JJ	O
American  	American  	 JJ	O
experts  	experts  	 NNS	O
meeting  	meeting  	 NN	B-NP
Patients  	Patients  	 NNS	I-NP
with  	with  	 IN	O
clinically  	clinically  	 JJ	B-NP
isolated  	isolated  	 JJ	I-NP
syndrome  	syndrome  	 NN	I-NP
( 	( 	 -LRB-	O
CIS 	CIS 	 NNP	B-NP
)  	)  	 -RRB-	O
by  	by  	 IN	O
definition  	definition  	 NN	O
do  	do  	 VBP	O
not  	not  	 RB	O
have  	have  	 VB	O
multiple  	multiple  	 JJ	B-NP
sclerosis  	sclerosis  	 NNS	I-NP
( 	( 	 -LRB-	O
MS 	MS 	 NNP	B-NP
)  	)  	 -RRB-	O
but  	but  	 CC	O
are  	are  	 VBP	O
at  	at  	 IN	O
risk  	risk  	 NN	O
of  	of  	 IN	O
developing  	developing  	 VBG	O
it 	it 	 PRP	O
.  	.  	 .	O
While  	While  	 IN	O
studies  	studies  	 NNS	O
show  	show  	 VBP	O
earlier  	earlier  	 RBR	O
immunomodulating  	immunomodulating  	 JJ	B-NP
drug  	drug  	 NN	I-NP
use  	use  	 NN	I-NP
is  	is  	 VBZ	O
effective 	effective 	 JJ	O
,  	,  	 ,	O
treatment  	treatment  	 NN	O
must  	must  	 MD	O
consider  	consider  	 VB	O
likely  	likely  	 JJ	O
patient  	patient  	 NN	O
prognosis 	prognosis 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
paper  	paper  	 NN	O
we  	we  	 PRP	O
review  	review  	 VBP	O
current  	current  	 JJ	O
diagnosis 	diagnosis 	 NN	O
,  	,  	 ,	O
prognosis 	prognosis 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
treatment  	treatment  	 NN	B-NP
literature  	literature  	 NN	I-NP
for  	for  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
CIS  	CIS  	 NNP	B-NP
within  	within  	 IN	O
Latin  	Latin  	 NNP	O
American  	American  	 NNP	O
clinical  	clinical  	 JJ	B-NP
settings 	settings 	 NNS	I-NP
.  	.  	 .	O
Latin  	Latin  	 NNP	O
American  	American  	 NNP	O
MS  	MS  	 NNP	B-NP
experts 	experts 	 NNS	I-NP
,  	,  	 ,	O
convened  	convened  	 VBN	O
by  	by  	 IN	O
ACINDES  	ACINDES  	 NNP	B-NP
( 	( 	 -LRB-	O
The  	The  	 DT	O
Civil  	Civil  	 NNP	O
Association  	Association  	 NNP	O
for  	for  	 IN	O
Research  	Research  	 NNP	O
and  	and  	 CC	O
Development  	Development  	 NNP	O
in  	in  	 IN	O
Health 	Health 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
reviewed  	reviewed  	 VBN	O
current  	current  	 JJ	O
CIS  	CIS  	 NNP	B-NP
( 	( 	 -LRB-	O
and  	and  	 CC	O
early  	early  	 JJ	O
MS 	MS 	 NNP	B-NP
)  	)  	 -RRB-	O
literature  	literature  	 NN	O
and  	and  	 CC	O
drew  	drew  	 VBD	O
consensus  	consensus  	 NN	B-NP
conclusions 	conclusions 	 NNS	I-NP
.  	.  	 .	O
Three  	Three  	 CD	O
subgroups  	subgroups  	 NNS	B-NP
addressed  	addressed  	 VBD	O
separate  	separate  	 JJ	O
questionnaires  	questionnaires  	 NN	O
on  	on  	 IN	O
CIS  	CIS  	 NNP	B-NP
issues 	issues 	 NNS	I-NP
:  	:  	 :	O
prognosis 	prognosis 	 CD	O
,  	,  	 ,	O
diagnosis 	diagnosis 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
MRI  	MRI  	 NNP	B-NP
can  	can  	 MD	O
contribute  	contribute  	 VB	O
to  	to  	 TO	O
predicting  	predicting  	 VBG	B-NP
MS  	MS  	 NNP	I-NP
risk  	risk  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
CIS 	CIS 	 NNP	B-NP
;  	;  	 :	O
in  	in  	 IN	O
Latin  	Latin  	 NNP	O
America 	America 	 NNP	O
,  	,  	 ,	O
investigation  	investigation  	 NN	B-NP
of  	of  	 IN	I-NP
haplotype  	haplotype  	 JJ	I-NP
presence  	presence  	 NN	I-NP
associated  	associated  	 VBN	O
with  	with  	 IN	O
CIS  	CIS  	 NNP	B-NP
would  	would  	 MD	O
be  	be  	 VB	O
appropriate 	appropriate 	 JJ	O
.  	.  	 .	O
McDonald 	McDonald 	 NNP	O
's  	's  	 POS	O
criteria  	criteria  	 NNS	O
and  	and  	 CC	O
subsequent  	subsequent  	 JJ	O
revisions  	revisions  	 NNS	O
enable  	enable  	 VBP	O
earlier 	earlier 	 RBR	O
,  	,  	 ,	O
more  	more  	 RBR	O
accurate  	accurate  	 JJ	O
MS  	MS  	 NNP	B-NP
diagnosis 	diagnosis 	 NN	I-NP
.  	.  	 .	O
Type  	Type  	 NN	O
A  	A  	 DT	O
evidence  	evidence  	 NN	O
exists  	exists  	 VBZ	O
supporting  	supporting  	 VBG	O
all  	all  	 DT	O
leading  	leading  	 JJ	O
immunomodulating  	immunomodulating  	 JJ	B-NP
MS  	MS  	 NN	I-NP
drugs  	drugs  	 NNS	I-NP
for  	for  	 IN	O
effective  	effective  	 JJ	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
CIS  	CIS  	 NNP	B-NP
with  	with  	 IN	O
a  	a  	 DT	O
high  	high  	 JJ	O
risk  	risk  	 NN	O
of  	of  	 IN	O
conversion  	conversion  	 NN	O
to  	to  	 TO	O
MS 	MS 	 NNP	B-NP
.  	.  	 .	O
In  	In  	 IN	O
conclusion 	conclusion 	 NN	O
,  	,  	 ,	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
CIS  	CIS  	 NNP	B-NP
are  	are  	 VBP	O
usually  	usually  	 RB	O
young 	young 	 JJ	O
,  	,  	 ,	O
with  	with  	 IN	O
often-limited  	often-limited  	 JJ	O
symptomatic  	symptomatic  	 JJ	B-NP
manifestations 	manifestations 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
must  	must  	 MD	O
be  	be  	 VB	O
adequately  	adequately  	 RB	O
prepared  	prepared  	 VBN	O
to  	to  	 TO	O
receive  	receive  	 VB	O
preventive  	preventive  	 JJ	B-NP
treatment 	treatment 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
consensus  	consensus  	 NN	B-NP
review  	review  	 NN	I-NP
should  	should  	 MD	O
contribute  	contribute  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
dialogue  	dialogue  	 NN	O
between  	between  	 IN	O
physicians  	physicians  	 NNS	O
and  	and  	 CC	O
patients 	patients 	 NNS	O
.  	.  	 .	O
